These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse. Wolf JE, Faanes RB, Choi YS. J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213 [Abstract] [Full Text] [Related]
13. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell. Fishelson Z, Berke G. J Immunol; 1978 Apr; 120(4):1121-6. PubMed ID: 305932 [Abstract] [Full Text] [Related]
15. The mechanism of T-cell mediated cytotoxicity. VIII. Zeiosis corresponds to irreversible phase (programming for lysis) in steps leading to lysis. Sanderson CJ. Immunology; 1981 Feb; 42(2):201-6. PubMed ID: 6970176 [Abstract] [Full Text] [Related]
17. Characterization of cells that suppress the cytotoxic activity of T lymphocytes. I. Quantitative measurement of inhibitor cells. Clark DA, Phillips RA, Miller RG. J Immunol; 1976 Apr; 116(4):1020-9. PubMed ID: 3606 [Abstract] [Full Text] [Related]
18. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. Maryanski JL, Boon T. Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608 [Abstract] [Full Text] [Related]